NR1H4 and lung carcinoma: There is a need for more research on FXR in lung cancer to explore the possibilities of using it as a reliable therapeutic target in lung cancer, and also to seek the use of different FXR-specific agonists and antagonists in order to target FXR for the prevention of lung cancer.